ENTITY
Grifols

Grifols (GRFS US)

13
Analysis
Health CareSpain
Grifols S.A. develops, manufactures, and markets plasma derivatives, IV Therapy, enteral nutrition, diagnostic systems, and medical materials.
more
bullishGrifols
08 Oct 2024 10:41Syndicated

Grifols A/B Spread (GRF.P) - Monday, Jul 8, 2024

A/B shares were issued in 2011 as part of an acquisition, allowing Grifols to expand its presence in the biopharmaceutical sector while maintaining...

Logo
180 Views
Share
bullishGrifols
19 Aug 2024 17:48

Liquid Universe of European Ordinary and Preferred Shares: August‘24 Report

Since mid-July, share-price spreads have generally widened across our European liquid universe of ordinary and preferred shares (9 have tightened,...

Share
bullishGrifols
18 Jul 2024 19:44

Liquid Universe of European Ordinary and Preferred Shares: July‘24 Report

Since mid-June, share-price spreads have generally tightened across our European liquid universe of ordinary and preferred shares (13 have...

Share
bullishGrifols
12 Jun 2024 18:46Syndicated

Grifols S A (GRFS) - Wednesday, Mar 13, 2024

Grifols, a biopharma company, has faced financial challenges but is making improvements and working towards a more stable future.

Logo
196 Views
Share
bearishGrifols
18 Mar 2024 06:55

Liquid Universe of European Ordinary and Preferred Shares: March‘24 Report

Since mid-February, spreads have not followed a clear pattern across our European liquid universe of ordinary and preferred shares (9 have...

Share
x